
Why Should I Trust You? The ACIP Turning Point: A Rallying Cry For A New Era of Public Health. A Talk w Drs. Craig Spencer, Rachael Bedard & Michael Mina
Dec 11, 2025
In a thought-provoking discussion, Dr. Michael Mina, an influential epidemiologist, and Dr. Rachael Bedard, a dedicated internist and health advocate, dive into the controversial ACIP decision to end the universal Hepatitis B birth dose. They challenge the implications this decision has on childhood vaccination and public trust in health systems. Exploring vaccine hesitancy, the importance of integrating sociology into public health, and lessons from COVID-19, they urge a shift from fear-based messaging to community engagement for better health outcomes.
AI Snips
Chapters
Transcript
Episode notes
Origins And Impact Of The 1991 Birth-Dose Policy
- The 1991 ACIP birth-dose policy aimed to close prenatal screening gaps and curb lifelong pediatric hepatitis B.
- That universal approach dramatically reduced hepatitis B cases but originally allowed vaccination flexibility to two months for screened-negative mothers.
Process Broke From Established ACIP Norms
- This ACIP process deviated from prior norms: there was no dedicated hepatitis B workgroup or long preparatory review.
- The meeting looked ideologically driven rather than following the usual methodical, evidence-based ACIP procedure.
How Hep B Questions Spark Wider Doubts
- Craig Spencer recalled pediatric clinicians being radicalized into vaccine skepticism after encountering hepatitis B questions.
- He described hepatitis B as an early "entry" topic that pulled clinicians into broader anti-vaccine circles.
